Shermaine Tilley

Director/Board Member at

Xagenic, Inc.

74 year

93 connections

Health Technology

Consumer Services

Finance

Profile

Shermaine Tilley is currently a Director at Xagenic, Inc., CellAegis Devices, Inc., Phemi Systems Corp., Rotman School of Management, CTI Capital, Inc., CFA Society Toronto, and CTI Life Sciences Fund LP.
He previously worked as a Director at Zymeworks BC, Inc., NeurAxon, Inc., BIOTECanada, Public Health Research Institute Center, and Chlorion Pharma, Inc. He was also a Senior Vice President at DRI Capital, Inc. and a Principal at New York University School of Medicine.
Tilley holds an MBA from the University of Toronto and a doctorate from The Johns Hopkins University School of Medicine.

Shermaine Tilley active positions

Companies	Position	Start
Xagenic, Inc. Xagenic, Inc. Medical SpecialtiesHealth Technology Develops automated molecular diagnostic platform will enable widespread decentralized testing to be performed outside of clinical laboratories	Director/Board Member	01/01/2012
Rotman School of Management Rotman School of Management Other Consumer ServicesConsumer Services Functions as a College/University	Corporate Officer/Principal	01/01/2002
CTI Life Sciences Fund LP CTI Life Sciences Fund LP Investment ManagersFinance Acts as Venture Capital Fund	Corporate Officer/Principal	01/08/2006
CFA Society Toronto CFA Society Toronto Miscellaneous Commercial ServicesCommercial Services Operates as a not-for-profit organization affiliated with CFA institute	Corporate Officer/Principal	-
Phemi Systems Corp. Phemi Systems Corp. Data Processing ServicesTechnology Services Operates as a big data warehouse company	Director/Board Member	01/06/2015
CTI Capital, Inc. CTI Capital, Inc. Investment ManagersFinance CTI Capital Inc. offers debt and equity trading, portfolio management, research, retail brokerage and investment banking services. They specialize in initial public offerings and new issues, private placements, reverse takeovers, capital pool companies, mergers and acquisitions and exchange sponsorships for emerging growth-oriented companies. The firm's equity research focuses on continuous global monitoring of the Canadian stock market. Their strategies are based on the evaluation of economic, financial and technical data. The firm employs market call systems that are based on fundamental and technical factors. Their fixed-income research seeks to identify the optimal strategy for the term, duration and tactical opportunities between different sectors of the market. The CTI Sciences Fund is a venture capital fund that invests primarily in companies located in Quebec and Canada. The Fund focuses on investments in biotechnological or biopharmaceutical products and medical devices. The financial partners of this private venture are the Caisse de dépôt et placement du Québec, Fonds de solidarité FTQ, FIER Partenaires S.E.C. and the Régime des rentes du Mouvement Desjardins.	Private Equity Investor	-
CellAegis Devices, Inc. CellAegis Devices, Inc. Electronic Equipment/InstrumentsElectronic Technology Develops device for the treatment of cardiac patients	Director/Board Member	-

All active positions of Shermaine Tilley

Former positions of Shermaine Tilley

Companies	Position	End
IMV INC.	Director/Board Member	27/03/2023
Zymeworks BC, Inc. Zymeworks BC, Inc. BiotechnologyHealth Technology Develops protein therapeutics for the treatment of cancer, autoimmune and inflammatory diseases	Director/Board Member	10/05/2017
░░░░░░░░░░░	░░░░░░░░░░░░░░ ░░░░░░	-
░░░ ░░░░ ░░░░░░░░░░ ░░░░░░ ░░ ░░░░░░░░	░░░░░░░░░ ░░░░░░░░░░░░░░░░░	-
░░░░░░░░░ ░░░░	░░░░░░░░░░░░░░ ░░░░░░	-

See the detail of Shermaine Tilley's experience

Training of Shermaine Tilley

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Shermaine Tilley's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	17
DRI Healthcare DRI Healthcare Investment ManagersFinance DRI Healthcare invests in royalty interests in leading pharmaceutical and biotechnology companies, research institutions, universities and inventors.	Finance
Zymeworks BC, Inc. Zymeworks BC, Inc. BiotechnologyHealth Technology Develops protein therapeutics for the treatment of cancer, autoimmune and inflammatory diseases	Health Technology
Rotman School of Management Rotman School of Management Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
CTI Capital, Inc. CTI Capital, Inc. Investment ManagersFinance CTI Capital Inc. offers debt and equity trading, portfolio management, research, retail brokerage and investment banking services. They specialize in initial public offerings and new issues, private placements, reverse takeovers, capital pool companies, mergers and acquisitions and exchange sponsorships for emerging growth-oriented companies. The firm's equity research focuses on continuous global monitoring of the Canadian stock market. Their strategies are based on the evaluation of economic, financial and technical data. The firm employs market call systems that are based on fundamental and technical factors. Their fixed-income research seeks to identify the optimal strategy for the term, duration and tactical opportunities between different sectors of the market. The CTI Sciences Fund is a venture capital fund that invests primarily in companies located in Quebec and Canada. The Fund focuses on investments in biotechnological or biopharmaceutical products and medical devices. The financial partners of this private venture are the Caisse de dépôt et placement du Québec, Fonds de solidarité FTQ, FIER Partenaires S.E.C. and the Régime des rentes du Mouvement Desjardins.	Finance
University of Toronto University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
CFA Society Toronto CFA Society Toronto Miscellaneous Commercial ServicesCommercial Services Operates as a not-for-profit organization affiliated with CFA institute	Commercial Services
NeurAxon, Inc. NeurAxon, Inc. Miscellaneous Commercial ServicesCommercial Services Researches and develops nervous system disorder therapies	Commercial Services
CTI Life Sciences Fund LP CTI Life Sciences Fund LP Investment ManagersFinance Acts as Venture Capital Fund	Finance
BIOTECanada BIOTECanada BiotechnologyHealth Technology Engages in research and development in biotechnology	Health Technology
Public Health Research Institute Center Public Health Research Institute Center Medical/Nursing ServicesHealth Services Provides biomedical research	Health Services
Chlorion Pharma, Inc. Chlorion Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services Develops small molecule leads for the treatment of naturopathic pain and epilepsy	Commercial Services
IMV, Inc. IMV, Inc. BiotechnologyHealth Technology Operates as a clinical-stage immuno-oncology company	Health Technology
Xagenic, Inc. Xagenic, Inc. Medical SpecialtiesHealth Technology Develops automated molecular diagnostic platform will enable widespread decentralized testing to be performed outside of clinical laboratories	Health Technology
CellAegis Devices, Inc. CellAegis Devices, Inc. Electronic Equipment/InstrumentsElectronic Technology Develops device for the treatment of cardiac patients	Electronic Technology
Phemi Systems Corp. Phemi Systems Corp. Data Processing ServicesTechnology Services Operates as a big data warehouse company	Technology Services
The Johns Hopkins University School of Medicine The Johns Hopkins University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
New York University School of Medicine New York University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services